Hong Kong · SFC › Firms

CStone Pharmaceuticals

基石藥業

Hong Kong listed company Stock code 2616

Board members with SFC licence histories

Back to top ↑
NamePositionFromTo
Hitchner III, Kenneth WaltonNon-Executive Director 10 Dec 2021present (as of 24 Dec 2025)
Cao, Yanling曹彥凌Non-Executive Director 15 May 201918 Jan 2023
Tong, Xiaomeng童小幪Non-Executive Director 28 Feb 201815 May 2019

Listings

Back to top ↑
MarketStock codeFirst tradedDelisted
SEHK Main Board261626 Feb 2019—

Former names

Back to top ↑
  • CStone Pharmaceuticals · until 18 Feb 2019

Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.